Vera Chirulli
C.V.

Pubblicazioni su riviste internazionali

L. Pucci, D. Lucchesi, V. Chirulli, G. Penno, I. Johansson, P.G. Gervasi, S. Del Prato and V. Longo (2003) Cytochrome P450 2J2: Polymorphism in Healthy Caucasian and those with Diabetes Mellitus Am. J. Pharmacog. 3: 355-358

L. Pucci, V. Chirulli, S. Marini, D. Lucchesi, G. Penno, P.G. Gervasi, S. Del Prato and V. Longo (2005) Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals Pharmac. Res. 51: 561-5

V. Chirulli, V. Longo, S. Marini, A. Mazzaccaro, R. Fiorio and P.G. Gervasi (2005) CAR and PXR expression and inducibility of CYP 2B and CYP3A activities in rat and rabbit lungs Life Science 76: 2535-2546

L. Marvasi, A. Zaghini, P.G. Gervasi, E. Vaccaro and V. Chirulli (2006) Induction of cytochrome P450 1A by â-naphtoflavone within the pig liver and central nervous system Vet. Res. Commun. 30: 333-336

V.O. Pustylnyak, V. Chirulli, P.G. Gervasi, D. Yaroslavtsev, L.F. Gulyaeva and V.V. Lyakhovich (2006) Effect of triphenyldioxane on phase I xenobiotic metabolism enzymes in the liver of rats and rabbits Bull. Exper. Biol. Medic. 141: 698-700

V. Chirulli, L. Marvasi, A. Zaghini, R. Fiorio, V. Longo and P.G. Gervasi (2007) Inducibility of Ahr-regulated genes by â-naphtoflavone in the liver, lung and heart of pigs Toxicology 240: 25-37

V. Longo, V. Chirulli, P.G. Gervasi, S. Nencioni, M. Pellegrini (2007) Effect of Lisosan ® G, a ground of grain, on the hepatic drug metabolizing enzymes and its protective role on carbon tetrachloride-induced hepatotoxicity, Biotechnology Letters 29:1115-9

A. Nannelli, V. Chirulli, V. Longo, P.G. Gervasi (2008) Expression and induction by rifampicin of CAR- and PXR- regulated CYP2B and CYP3A in liver, kidney and airways of pig, Toxicology 252 (1-3):105-12

A. Messina, V. Chirulli, P.G. Gervasi, V. Longo (2008) Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2, Xenobiotica 38(12):1453-70

 

Pubblicazioni su riviste nazionali

V. Longo, V. Chirulli: Farmaci personalizzati: massima efficacia e minor effetti indesiderati (2003) Biologi Italiani, anno XXIII - n.8: 11-15

 

Comunicazioni a congressi internazionali

D. Lucchesi, V. Longo, L. Pucci, V. Chirulli, G. Penno, R. Miccoli, I. Johansson, P.G. Gervasi, S. Del Prato: CYP2J*6 polymorphism in healthy and diabetic caucasian: in searching for a relantionship with complications. Diabetes  & Metabolism, 18th International Diabetes Federation Congress, p.468. August 24-29, 2003, Parigi, Francia.

V. Longo, L. Pucci, D. Lucchesi, V. Chirulli, G. Penno, R. Miccoli, I. Johansson, P.G. Gervasi, S. Del Prato: CYP2J*6 polymorphism in healthy and diabetic caucasian: in searching for a relantionship with complications. Diabets, Vol. 52 supplement 1, p. A482. 63rd scientific session June 13-17, 2003, New Orleans, Louisiana

V. Longo, I. Johansson, L. Pucci, D. Lucchesi, V. Chirulli, G. Penno, R. Miccoli, P.G. Gervasi, S., Del Prato: CYP2J*6 polymorphism in healthy and diabetic caucasians: in searching for a relationship with complications. European Diabetic Nephropathy Study group: 16th Annual Meeting, May 2-3, 2003, Elsinore, Denmark

P.G. Gervasi, V. Chirulli, A. Zaghini, E. Vaccaro, R. Fiorio, V. Longo, L. Marvasi: Expression and activity of CYP 1A1 in different regions of control and âNF-trested pigs First PharmSciFair, 12-17 Giugno 2005, Nizza, Francia

V. Chirulli, R. Fiorio, S. Bertocchini, L. Marvasi, V. Longo, P.G. Gervasi: Inducibility of AhR- regulated genes by â-naphtoflavone in the liver, lung and heart of pig (comunicazione orale) 10th International Congress E.A.V.P.T. 17-22 settembre 2006, Torino, Italia

 

Comunicazioni a congressi nazionali

L. Pucci, D. Lucchesi, C. Fotino, S. Triscornia, V. Chirulli, V. Longo, R. Miccoli, G. Penno, S. Del Prato: Leu55Met Paraoxonase polymorphism is associated with diabetic nepropathy but not retinopathy in type 2 diabetes. European Diabetic Nephropathy Study Group 17th Annual Meeting, Maggio 7-8, 2004, Bergamo, Italia

V. Chirulli: Expression and inducibility of CAR and PXR Receptor and CYP 2B and CYP3A activities in rat and rabbit lungs VIII Seminario nazionale per dottorandi in farmacologia e scienze affini. 20-23 Settembre 2004, Siena, Italia

V. Longo, L. Pucci, V. Chirulli, S. Nencioni, P.G. Gervasi Cytochrome P450 2D6, 2J2, 1A2 polymorphism in italian population Convegno: “Citocromo P450: aspetti farmacologici, tossicologici e ambientali” 12-13 Settembre 2005, Siena, Italia.

V. Chirulli, P.G. Gervasi, A. Zaghini, E. Vaccaro, R. Fiorio, V. Longo, L. Marvasi: Analysis of CYP1A1 in different brain regions of control and âNF-treated pigs Convegno: “Citocromo P450: aspetti farmacologici, tossicologici e ambientali” 12-13 Settembre 2005, Siena, Italia

V. Chirulli: Drug-metabolizing system in liver and lung of control and â-naphtoflavone-treated pigs IX Seminario Nazionale per dottorandi in farmacologia e scienze affini. 20-23 Settembre 2005, Siena, Italia.

V. Chirulli, R. Fiorio, V. Longo, L. Marvasi, P.G. Gervasi: Effetto del â-naftoflavone sull’espressione di alcune isoforme P450 e di enzimi di fase II nel polmone di suino XIV Congresso Nazionale SITOX, 6-9 febbraio 2006, Roma, Italia.

V. Chirulli: Expression and regulation of cytochrome P450 and phase II enzymes in the lung of rat, rabbit and pig (comunicazione orale) X Seminario Nazionale per dottorandi in farmacologia e scienze affini, 25-28 Settembre 2006, Siena, Italia.